市场调查报告书
商品编码
1471308
人工水晶体市场:按类型、材料和最终用户划分 - 2024-2030 年全球预测Intraocular Lens Market by Type (Phakic IOLs, Premium IOLs, Traditional/Monofocal IOLs), Material (Foldable IOLs, PMMA IOLs), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年人工水晶体市场规模为42.7亿美元,预计2024年将达45.7亿美元,2030年将达70.6亿美元,复合年增长率为7.44%。
当自然水晶体变得混浊或受损(例如白内障)时,将人工水晶体(人工水晶体)植入眼睛以取代自然水晶体。人工水晶体在眼科领域有广泛的用途,主要最终用途是白内障患者的矫正手术。由于与老龄化相关的眼科疾病患病率不断上升,人们对眼保健服务的认识不断提高,越来越多的人认识到定期眼科检查的重要性,以及获得先进治疗选择的机会增加,预计人工水晶体的需求将会增加。然而,人工水晶体植入手术的高成本和风险,如感染、发炎和水晶体脱位,阻碍了市场需求。水晶体材料的创新和设计提高了人工水晶体的功能和性能,使其成为许多情况下视力矫正的首选。已开发国家的患者越来越多地在国外寻求负担得起的医疗保健,特别是在以高品质眼部保健服务而闻名的国家,这可能会进一步推动对人工水晶体的需求。
主要市场统计 | |
---|---|
基准年[2023] | 42.7亿美元 |
预测年份 [2024] | 45.7亿美元 |
预测年份 [2030] | 70.6亿美元 |
复合年增长率(%) | 7.44% |
类型患者有水晶体人工水晶体的采用率较高
有水晶体人工水晶体适用于严重近视、远视和散光的患者。这些镜片旨在与眼睛的天然晶状体配合使用,而不是取代它。优质人工水晶体具有先进的功能,可解决传统白内障治疗以外的特定视觉状况。这些镜片通常可以提供更好的屈光效果,旨在减少手术后对框架眼镜或隐形眼镜的依赖。白内障手术后,传统的或单焦点的人工水晶体聚焦在通常很远的单点上。这些镜片是最基本的选择,术后患者通常需要这些基本眼镜来执行近距离或中间视力任务。
材质:折迭式人工水晶体切口较小,因此术后恢復较快。
如今,折迭式人工水晶体已成为白内障手术的热门选择,因为它们可以透过小切口插入,从而加快癒合速度并缩短恢復时间。这些镜片主要由柔软、有弹性的材料製成,例如硅胶、疏水性丙烯酸和亲水性丙烯酸。基于需求的折迭式人工水晶体的偏好源于併发症风险的降低、伤口稳定性的改善以及术后患者的舒适度。聚甲基丙烯酸甲酯 (PMMA) 自白内障手术早期就开始使用,因为它具有高生物相容性和光学透明度。当折迭式镜片停用时(例如对硅树脂过敏的患者)或考虑成本时,PMMA人工水晶体是首选。
最终用户:人工水晶体广泛应用于眼科诊所以提供个人化治疗。
门诊手术中心 (ASC) 是进行门诊外科手术的现代化医疗机构,包括白内障手术(包括人工水晶体植入)。这些中心需要为其患者提供高效且经济高效的人工水晶体。眼科研究所专注于创新研究计划,为白内障和老花眼等眼科疾病开发尖端解决方案。我们也与产业合作伙伴合作,利用优质材料和技术开发先进的人工水晶体,例如复曲面和多焦点人工水晶体。医院和诊所是人工水晶体植入服务的主要提供者,为不同的患者群体提供服务。需要具有不同特性(例如材料、设计和成本)的人工水晶体来满足患者的特定需求。眼科诊所专注于眼科疾病的治疗,通常根据患者的个人需求提供个人化护理。这些诊所通常更喜欢优质的人工水晶体还具有其他优点,例如减少眩光和提高对比敏感度。
区域洞察
由于眼部相关疾病的盛行率不断上升、用于术后视力恢復的人工水晶体技术进步以及微创手术的高消费支出等因素,美洲成为人工水晶体的重要地区。糖尿病患者数量的增加也导致对人工水晶体的需求增加。在欧盟(EU),老年人口增加、眼科疾病率上升、先进医疗基础设施的可用性以及各种政府措施等因素正在推动人工水晶体市场的成长。在中东和非洲地区,由于人口成长,人们对眼保健服务的认识不断提高,因此对人工水晶体的需求不断增加。此外,该地区各国政府正在投资医疗基础设施开发计划,其中包括最先进的眼保健设施,从而改善视力矫正手术的机会。由于眼科疾病率不断上升、医疗基础设施不断扩大以及政府对研究倡议的支持,亚太地区成为人工水晶体的重要市场。
FPNV定位矩阵
FPNV定位矩阵对于评估人工水晶体市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对人工水晶体市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,以获得市场竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.人工水晶体市场规模及预测如何?
2.人工水晶体市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.人工水晶体市场的技术趋势和法规结构是什么?
4.人工水晶体市场主要厂商的市场占有率是多少?
5.进入人工水晶体市场的合适型态和策略手段是什么?
[199 Pages Report] The Intraocular Lens Market size was estimated at USD 4.27 billion in 2023 and expected to reach USD 4.57 billion in 2024, at a CAGR 7.44% to reach USD 7.06 billion by 2030.
An intraocular lens (IOL) is embedded inside the eye to replace its natural lens when it becomes cloudy or damaged, typically due to cataracts. Intraocular lenses have a wide range of applications in the field of ophthalmology, with the primary end-use being corrective surgery for cataract patients. With a higher prevalence of age-related eye diseases, rising awareness, and accessibility to eye care services as more people become aware of the importance of regular eye check-ups and access to advanced treatment options improve, demand for IOLs is expected to rise. However, high intraocular lens costs and risks associated with IOL implantation surgery, including infection, inflammation, and lens dislocation, hamper its market demand. Innovations in lens material technology and design have improved the functionality and performance of intraocular lenses, making them the preferred option for vision correction in many cases. Patients from developed countries increasingly seek affordable healthcare options abroad, particularly in countries with a reputation for high-quality eye care services, which can further boost the demand for IOLs.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.27 billion |
Estimated Year [2024] | USD 4.57 billion |
Forecast Year [2030] | USD 7.06 billion |
CAGR (%) | 7.44% |
Type: High adoption of phakic intraocular lenses among patients
Phakic intraocular lenses are used for patients with high levels of myopia, hyperopia, or astigmatism. These lenses are designed to work with the eye's natural lens rather than replacing it. Premium intraocular lenses offer advanced features that cater to specific visual conditions beyond traditional cataract treatment. These lenses often provide better refractive outcomes and aim to reduce dependency on eyeglasses or contact lenses post-surgery. Traditional or mono-focal intraocular lenses provide a single focus point at one distance, usually far after cataract surgery. These lenses are the most basic option, and patients typically require these basic eyeglass for near or intermediate vision tasks post-surgery.
Material: Poliferating use of foldable IOLs due to their smaller incision size requirement leading to faster recovery times
Foldable IOLs are a popular choice in modern cataract surgery because they can be inserted through small incisions, leading to faster healing and reduced recovery time. These lenses are primarily made from soft and flexible materials such as silicone, hydrophobic acrylic, and hydrophilic acrylic. The need-based preference for foldable IOLs arises from their reduced risk of complications, better wound stability, and patient comfort during the postoperative period. Polymethyl methacrylate (PMMA) intraocular lenses have been used since the early days of cataract surgery as they offer a high degree of biocompatibility and optical clarity. The need-based preference for PMMA IOLs arises in cases where patients have contraindications to foldable lenses, such as those with silicone allergy, or when cost is a major consideration.
End-User: Extensive use of IOL in ophthalmology clinics to offer personalized care
Ambulatory surgery centers (ASCs) are modern healthcare structures that perform outpatient surgical procedures, including cataract surgery with intraocular lens implantation. These centers require efficient and cost-effective intraocular lenses for their patients. Eye research institutes focus on innovative research projects to develop cutting-edge solutions for eye disorders such as cataracts and presbyopia. They often collaborate with industry partners to develop advanced intraocular lenses with superior materials or technologies, such as toric or multifocal IOLs. Hospitals and clinics are the primary providers of intraocular lens implantation services, catering to a diverse patient population. To meet patients ' specific needs, they require a wide range of intraocular lenses with varying features, such as material, design, and cost. Ophthalmology clinics specialize in treating eye disorders and typically offer personalized care based on individual patient requirements. These clinics often prefer premium intraocular lenses that offer additional benefits such as reduced glare or improved contrast sensitivity beyond standard postoperative visual acuity.
Regional Insights
The Americas has a significant landscape in the intraocular lens owing to factors such as the increasing prevalence of eye-related diseases, technological advancements in IOLs for better visual outcomes post-surgery, and high consumer expenditure on minimally invasive procedures. The rising cases of diabetes also contribute to a higher demand for IOLs. In the European Union, factors such as the growing geriatric population, rising incidences of eye diseases, availability of advanced healthcare infrastructure, and various government initiatives are driving growth in the intraocular lens market. The Middle East and Africa region is noticing a rise in demand for intraocular lenses due to increased awareness about eye health care services among the growing population. Furthermore, governments across this region are investing in healthcare infrastructure development projects incorporating state-of-the-art ophthalmic facilities, resulting in greater accessibility to vision correction surgeries. APAC region constitutes a significant market for intraocular lenses due to the increasing prevalence of eye disorders, expansion of healthcare infrastructure, and government support for research initiatives.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Intraocular Lens Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intraocular Lens Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Intraocular Lens Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Aurolab, Bausch Health Companies Inc., Benq Materials Corporation, Care Group Inc., Carl Zeiss AG, Essilor International SAS, EyeKon Medical, Inc., Himalaya Optical, Hoya Corporation, HumanOptics AG, Johnson and Johnson Surgical Vision, Inc., Lenstec Inc., Menicon Co., Ltd., Novartis AG, Omni Lens Pvt. Ltd., Ophtec B.V., PhysIOL S.A., Rayner Intraocular Lenses Limited, SAV IOL S.A., Shanghai Haohai Biological Technology Co. Ltd., and STAAR Surgical Company.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Intraocular Lens Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intraocular Lens Market?
3. What are the technology trends and regulatory frameworks in the Intraocular Lens Market?
4. What is the market share of the leading vendors in the Intraocular Lens Market?
5. Which modes and strategic moves are suitable for entering the Intraocular Lens Market?